作者: Ignatios Ikonomidis , Ioannis Paraskevaidis , Alexandra Frogoudaki , Konstantinos Voumvourakis , John Parissis
DOI:
关键词:
摘要: BackgroundP 49.2% males; median NIHSS=5 (IQR, 3-8)]. TEE revealed additional findings in 52.4% (95%CI by the adjusted Wald method: 40.2%-64.5%) of patients. Patent foramen ovale (PFO) and atrial septal aneurysm (ASA) were reported 27.8% (95%CI: 18.1%-40.2%) 13.1% 6.5%-24.1%) study population respectively. The concurrence PFO ASA was 4 patients (6.5%, 95%CI: 2.1%-16.1%). presence valvular vegetations documented 2 (3.2%; 0%-11.8%), while thrombus found left atrium one patient (1.6%, 0%-9.5%). Complex aortic arch atheromatosis 6.5% 2.1%-16.1%) Neither myxomas, nor ventricular defects examinations. changed management 16.4% 8.9%-27.8%) Anticoagulants initiated 5 patients, other with endocarditis received treatment intravenous antibiotics. Finally, 3 61 underwent a PFO-closure procedure due to large size shunt previous history recurrent cryptogenic IS. Conclusions: Our suggest that ESUS should undergo investigation search potential cardioembolic or aortogenic sources. may have decisive impact on selection appropriate therapeutic approach for these